Voyager Therapeutics (VYGR) EBT Margin Growth (5y) (2020 - 2026)
Powered by 
Analysis
Voyager Therapeutics (VYGR) EBT Margin Growth (5y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.23 Bn | 9.38 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.05 Bn | 5.05 Bn | - |
| 3 | Iovance Biotherapeutics | 3.76 Bn | 3.46 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.59 Bn | 2.63 Bn | 251.50 Mn |
| 5 | uniQure | 3.01 Bn | 3.01 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.22 Bn | 1.42 Bn | 251.87 Mn |
| 9 | Vericel | 1.96 Bn | 1.80 Bn | 56.40 Mn |
| 10 | Voyager Therapeutics | 192.24 Mn | 75.90 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 134,255.00 |
| Mar 31, 2026 | -68,051.00 |
| Dec 31, 2025 | 18,298.00 |
| Sep 30, 2025 | -27,947.00 |
| Jun 30, 2025 | -60,940.00 |
| Mar 31, 2025 | -34,435.00 |
| Dec 31, 2024 | -50,155.00 |
| Sep 30, 2024 | 3,689.00 |
| Jun 30, 2024 | -5,838.00 |
| Mar 31, 2024 | 46,482.00 |
| Dec 31, 2023 | 118,559.00 |
| Sep 30, 2023 | 40,372.00 |
| Jun 30, 2023 | 53,986.00 |
| Mar 31, 2023 | 221,729.00 |
| Dec 31, 2022 | 170,914.00 |
| Sep 30, 2022 | 207,652.00 |
| Jun 30, 2022 | -109,359.00 |
| Mar 31, 2022 | -208,737.00 |
| Dec 31, 2021 | 62,420.00 |
| Sep 30, 2021 | -140,749.00 |